Five medications are FDA-approved specifically for obsessive-compulsive disorder, and all of them work by increasing serotonin activity in the brain. Four are SSRIs (selective serotonin reuptake inhibitors), and one is an older tricyclic antidepressant. OCD typically requires higher doses and longer treatment timelines than depression, so understanding what to expect from medication can make a real difference in sticking with treatment long enough for it to work.
FDA-Approved Medications for OCD
The five medications with specific FDA approval for OCD are:
- Fluoxetine (Prozac), approved for adults and children 7 and older
- Fluvoxamine (Luvox), approved for adults and children 8 and older
- Sertraline (Zoloft), approved for adults and children 6 and older
- Paroxetine (Paxil), approved for adults only
- Clomipramine (Anafranil), approved for adults and children 10 and older
The first four are SSRIs. Clomipramine is a tricyclic antidepressant that also targets serotonin but affects other brain chemicals too, which is why it tends to cause more side effects. All five work by making more serotonin available in the brain, and this serotonin boost appears to be what reduces the intensity of obsessive thoughts and compulsive urges.
Why OCD Doses Are Higher Than for Depression
One of the most important things to know about OCD medication is that the effective dose is often at the upper end of the approved range, sometimes higher than what’s used for depression. Fluoxetine for depression might work at 20 mg per day, but OCD treatment can require up to 80 mg. Sertraline ranges from 100 to 200 mg for OCD, compared to 50 to 150 mg for typical depression treatment.
This means that if you start at a low dose and don’t notice much change, that’s expected. Your prescriber will likely increase the dose gradually, aiming for the higher end of the range unless side effects become a problem. It’s not a sign that the medication isn’t working for you if the starting dose doesn’t do much.
How Long Before Medication Works
OCD medication takes longer to show its full effect than most people expect. A meta-analysis published in the Journal of Clinical Psychiatry found that some measurable improvement can appear within two weeks of starting an SSRI. But that early response is subtle, and clinical guidelines recommend giving any SSRI a full trial of 10 to 12 weeks before deciding it isn’t working.
That’s a long time to wait, and many people give up too early. The gradual nature of improvement can make it hard to notice changes week to week. Keeping a simple log of how much time you spend on compulsions or how distressing your intrusive thoughts feel can help you and your prescriber track whether the medication is actually making a difference over those weeks.
SSRIs vs. Clomipramine
Clomipramine was the first medication shown to work for OCD and has long been considered highly effective. However, SSRIs are now preferred as the first choice for most people, largely because of tolerability. In a head-to-head trial comparing sertraline to clomipramine, sertraline actually showed a slight edge in effectiveness, with patients improving about 51% on a standard OCD symptom scale compared to 43% for clomipramine. But the real difference was in side effects: 26% of people on clomipramine dropped out due to adverse reactions, compared to just 11% on sertraline.
Clomipramine can cause dry mouth, constipation, dizziness, sedation, and weight gain more frequently than SSRIs. It also carries a risk of heart rhythm changes at higher doses. For these reasons, most prescribers start with an SSRI and reserve clomipramine for people who haven’t responded to at least two SSRI trials.
Common Side Effects at OCD Doses
Because OCD often requires higher doses, side effects are worth understanding. A study tracking patients on various SSRI dose levels found the most common complaints were sexual dysfunction (34% of patients), weight gain (27%), sedation (26%), excessive sweating (19%), and tremor (10%). Notably, these rates didn’t differ much between moderate and very high dose groups, suggesting that side effects tend to show up early and don’t necessarily get worse as the dose climbs.
No cases of serotonin syndrome were recorded in that study, even among patients on the highest doses. Serious complications like seizures or liver enzyme elevations were rare. Most side effects are manageable, and some, like nausea or sedation, tend to ease after the first few weeks.
When the First Medication Doesn’t Work
About 40 to 60% of people with OCD respond well to their first SSRI trial. If you’re in the group that doesn’t, the typical next step is trying a different SSRI. Each one has a slightly different chemical profile, and it’s common for someone to respond better to one than another for reasons that aren’t fully predictable.
If two or more SSRIs haven’t helped enough, your prescriber may add a low dose of a second medication on top of the SSRI. This approach, called augmentation, most commonly involves antipsychotic medications. A network meta-analysis comparing several options found that aripiprazole had the strongest evidence for boosting SSRI effectiveness in treatment-resistant OCD. Risperidone also showed benefit. Quetiapine, while sometimes used, was significantly less well tolerated than placebo in the analysis.
These augmenting medications are used at much lower doses than when they’re prescribed for conditions like schizophrenia. They’re not replacing the SSRI but working alongside it.
Medication and Therapy Together
OCD medications work best when combined with a specific type of cognitive behavioral therapy called exposure and response prevention (ERP). In ERP, you gradually face situations that trigger your obsessions while practicing not performing compulsions. Medication can lower the intensity of obsessive thoughts enough to make this therapy more effective, and therapy builds skills that medication alone doesn’t provide.
For mild to moderate OCD, some people do well with therapy alone. For moderate to severe OCD, the combination of an SSRI and ERP consistently produces better outcomes than either treatment by itself. If you’re starting medication, asking about access to ERP therapy is one of the most useful steps you can take.
How Long You’ll Stay on Medication
Most guidelines recommend continuing OCD medication for at least one to two years after symptoms have stabilized. Stopping too early carries a high risk of relapse. When it is time to taper, the process should be gradual, typically over several months, to minimize withdrawal symptoms and reduce the chance of OCD symptoms returning. People who’ve also completed a course of ERP therapy tend to have lower relapse rates when they eventually discontinue medication.